|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| C07K 14/47 | (2006.01) |
| (11) | Number of the document | 1781703 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05753672.4 |
| Date of filing the European patent application | 2005-06-21 | |
| (97) | Date of publication of the European application | 2007-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2015-05-06 |
| (46) | Date of publication of the claims translation | 2015-07-27 |
| (86) | Number | PCT/SE2005/000993 |
| Date | 2005-06-21 |
| (87) | Number | WO 2005/123775 |
| Date | 2005-12-29 |
| (30) | Number | Date | Country code |
| 0401601 | 2004-06-21 | SE |
| (72) |
GELLERFORS, Pär, SE
LANNFELT, Lars, SE
|
| (73) |
BioArctic Neuroscience AB,
Warfvinges väg 35, 112 51 Stockholm,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai, specifiniai tirpioms beta amiloido peptidų protofibrilėms, ir jų panaudojimas |
| ANTIBODIES SPECIFIC FOR SOLUBLE AMYLOID BETA PEPTIDE PROTOFIBRILS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2019-05-27 | 15 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2017-09-26 |